Reposted by Iva Hafner Bratkovič
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines
www.nature.com/articles/s41... @lozanzi.bsky.social @harvardmed.bsky.social
@natimmunol.nature.com
Scientist, synthetic immunologist, loves minimalism. Interested in innate immunity, inflammasomes, cell death, inflammation, autoinflammatory diseases and cancer.